Techno Medica Co., Ltd. (TYO:6678)
Japan · Delayed Price · Currency is JPY 2,051.00
+56.00 (2.81%)
Aug 6, 2026, 11:22 AM JST
Techno Medica Revenue
In the fiscal year ending March 31, 2026, Techno Medica had annual revenue of 11.24B JPY with 13.44% growth. Techno Medica had revenue of 4.00B in the quarter ending March 31, 2026, with 15.60% growth.
Revenue
11.24B
Revenue Growth
+13.44%
P/S Ratio
1.24
Revenue / Employee
47.01M
Employees
239
Market Cap
13.90B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 11.24B | 1.33B | 13.44% |
| Mar 31, 2025 | 9.91B | -378.00M | -3.68% |
| Mar 31, 2024 | 10.28B | 916.00M | 9.78% |
| Mar 31, 2023 | 9.37B | -332.00M | -3.42% |
| Mar 31, 2022 | 9.70B | 659.00M | 7.29% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| PHC Holdings | 364.40B |
| Nihon Kohden | 235.10B |
| Japan Lifeline | 60.48B |
| DVx Inc. | 55.99B |
| Eiken Chemical | 42.43B |
| Seikagaku | 36.65B |
| Japan Medical Dynamic Marketing, INC. | 23.32B |
| Koken | 11.85B |